We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Roche Holdings Ltd AG (QX) | USOTC:RHHBY | OTCMarkets | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.07 | -0.23% | 29.75 | 29.55 | 30.50 | 30.05 | 29.53 | 29.80 | 5,444,214 | 21:57:01 |
By Ian Walker
Sensyne Health PLC (SENS.LN) said Monday that it has agreed to a research project with Roche Holding AG (RO.EB) to apply artificial intelligence for clinical trial design.
The British clinical AI technology company said the project will initially focus on identifying patient populations in one disease area and assessing and collating anonymized patient data with anonymized electronic patient record information to support clinical trial planning.
No financial terms were disclosed.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
December 23, 2019 05:16 ET (10:16 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Roche (QX) Chart |
1 Month Roche (QX) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions